Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer Consortium

Affiliations


Abstract

Background: Management of early-stage non-small cell lung cancer (ES-NSCLC) has evolved over the last few years especially in terms of work-up and the use of systemic therapy. This consensus statement was developed to present updated guidelines for the management of this disease.

Methods: Multidisciplinary team (MDT) of lung cancer experts convened to discuss a set of pertinent questions with importance relevance to the management of ES-NSCLC. ES-NSCLC includes stages I, II and resected stage III. The experts included consultants in chest imaging, thoracic surgery, radiation oncology, and medical oncology. Questions were discussed in virtual meetings and then a written manuscript with supporting evidence was drafted, reviewed, and approved by the team members.

Results: The Consensus Statement included 9 questions addressing work-up and management of ES-NSCLC. Background information and literature review were presented for each question followed by specific recommendations to address the questions by oncology providers. The Statement was endorsed by various oncology societies in the Gulf region.

Conclusion: The Consensus Statement serves as a guide for thoracic MDT members in the management of ES-NSCLC. Adaptation of these to the local setting is dictated usually by available resources and expertise, however, all efforts should be excreted to provide the optimal care to all patients whenever possible.

Keywords: Early Stage; Guidelines; Management; Non-small cell lung cancer.


Similar articles

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.

Califano R, Karamouzis MV, Banerjee S, de Azambuja E, Guarneri V, Hutka M, Jordan K, Kamposioras K, Martinelli E, Corral J, Postel-Vinay S, Preusser M, Porcu L, Torri V.Lung Cancer. 2014 Jul;85(1):74-80. doi: 10.1016/j.lungcan.2014.03.010. Epub 2014 Mar 16.PMID: 24746176

Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations.

Göker E, Altwairgi A, Al-Omair A, Tfayli A, Black E, Elsayed H, Selek U, Koegelenberg C.Lung Cancer. 2021 Aug;158:60-73. doi: 10.1016/j.lungcan.2021.05.025. Epub 2021 May 26.PMID: 34119934 Review.

Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.

Daly ME, Singh N, Ismaila N, Antonoff MB, Arenberg DA, Bradley J, David E, Detterbeck F, Früh M, Gubens MA, Moore AC, Padda SK, Patel JD, Phillips T, Qin A, Robinson C, Simone CB 2nd.J Clin Oncol. 2022 Apr 20;40(12):1356-1384. doi: 10.1200/JCO.21.02528. Epub 2021 Dec 22.PMID: 34936470 Review.

Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC.Chest. 2013 May;143(5 Suppl):e278S-e313S. doi: 10.1378/chest.12-2359.PMID: 23649443

Suicidal Ideation.

Harmer B, Lee S, Duong TVH, Saadabadi A.2023 Feb 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–.PMID: 33351435 Free Books & Documents.


Cited by

Recent advances in postoperative pulmonary rehabilitation of patients with non‑small cell lung cancer (Review).

Su XE, Hong WP, He HF, Lin S, Wu SH, Liu F, Lin CL.Int J Oncol. 2022 Dec;61(6):156. doi: 10.3892/ijo.2022.5446. Epub 2022 Nov 2.PMID: 36321778 Free PMC article. Review.


References

https://pubmed.ncbi.nlm.nih.gov/